Olympia Pharmaceuticals, a FDA-registered 503B outsourcing facility, has expanded its compounding capabilities to include a wide array of therapeutic peptides and injectable nutrients. The company highlights its ability to ship these medications nationwide for office use, bypassing traditional supply chain shortages. Their catalog includes popular peptides like GLP-1 agonists, BPC-157, and various growth hormone secretagogues, positioning them as a key supplier for the weight management and longevity sectors.